Skip to main content

Peer Review reports

From: Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol

Original Submission
12 Jan 2016 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
12 Jul 2016 Editorially accepted
19 Jul 2016 Article published 10.1186/s12885-016-2551-3

You can find further information about peer review here.

Back to article page